Company Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.

Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.

The company is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd.

Country	Israel
Founded	2015
Industry	Biotechnology
Sector	Healthcare
Employees	121
CEO	Uzi Sofer

Contact Details

Address: Kiryat HaMada St. 5 Jerusalem, 9777605 Israel
Phone	972 3 577 4115
Website	alphatau.com

Stock Details

Ticker Symbol	DRTS
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	1871321
CUSIP Number	M0740A108
ISIN Number	IL0011839383
SIC Code	3841

Key Executives

Name	Position
Uzi Sofer	Chief Executive Officer and Chairman
Raphi Levy	Chief Financial Officer
Amnon Gat	Chief Operations Officer
Ronen Segal	Chief Technology Officer
Dr. Robert B. Den M.D.	Chief Medical Officer and Member of Scientific Advisory Board
Prof. Yona Keisari	Chief Scientific Officer and Member of Scientific Advisory board
Rebecca Becker	Vice President of legal
Yael Zeiger	Corporate Controller

Latest SEC Filings

Date	Type	Title
Mar 31, 2026	6-K	Report of foreign issuer
Mar 9, 2026	S-8	Securities to be offered to employees in employee benefit plans
Mar 9, 2026	6-K	Report of foreign issuer
Mar 9, 2026	20-F	Annual and transition report of foreign private issuers
Feb 26, 2026	144	Filing
Feb 24, 2026	6-K	Report of foreign issuer
Feb 2, 2026	144	Filing
Jan 29, 2026	6-K	Report of foreign issuer
Jan 14, 2026	144	Filing
Jan 12, 2026	144	Filing

View All SEC Filings